News

Dr. Kaveh Alizadeh to Address Innovations in Migraine Surgery

Dr. Kaveh Alizadeh to Address Innovations in Migraine Surgery

Dr. Kaveh Alizadeh to Speak at a Leading Migraine Surgery Symposium

Dr. Kaveh Alizadeh, a board-certified plastic surgeon widely recognized for his work in migraine surgery, will take the virtual stage at the American Society of Plastic Surgery's Migraine Surgery Symposium. This marks the third year in a row he’s been invited to present at this gathering, which examines the science, anatomy, and surgical approaches tied to migraine trigger sites. It’s a forum built for deep dives and clear takeaways—how the nerves, soft tissues, and triggers connect, and how surgery can help.

Why Migraine Surgery Matters

The symposium brings together experts from multiple disciplines to share how the field is evolving and what’s working for people with chronic migraines. Dr. Alizadeh has been a steady voice in this space, advocating for carefully selected surgical interventions that can reduce the burden of disease for patients who’ve tried everything else. The aim is simple and hard-won: fewer headaches, better function, more days back.

What to Expect from the Online Program

The program convenes talented clinicians and researchers from around the world. Through panel discussions and focused presentations, they’ll compare techniques, discuss patient selection, and reflect on outcomes—what’s promising, what needs refinement, and what professionals can put to use right away. Attendees can expect practical insights on managing and treating migraines, grounded in experience and data.

Dr. Alizadeh’s Track Record

With more than a decade dedicated to migraine surgery, Dr. Alizadeh has treated over 1,000 patients with chronic migraines. His reported outcomes are notable: 92% of his patients no longer meet the criteria for chronic headaches after surgery. He also reports a sustained 60% cure rate, with many patients able to step away from prescription medications. The numbers tell a story, but so does the day-to-day impact—less pain and more normalcy.

Event Details and Dr. Alizadeh’s Schedule

The symposium will be held online, running from 8:30 a.m. to 5:00 p.m. EST. Dr. Alizadeh’s session will focus on the nuts and bolts of building a successful migraine practice—what to consider, how to start, and how to sustain quality care in different settings. Highlights from his schedule include:

  • 3:15 p.m. EST: Getting Started: Pearls of Starting Your Migraine Practice in Academic, Private Practice, and International Locations
  • 3:55 p.m. EST: Presentation of a Migraine Surgical Video
  • 4:45 p.m. EST: Wrap-Up Discussion and Q&A Session

Building Connections Across Specialties

As Dr. Alizadeh notes, progress here depends on teamwork. The symposium creates space for collaboration among neurologists, pain management specialists, psychiatrists, and surgeons. That kind of network helps clinicians share results, compare protocols, and ultimately improve patient care—locally and across borders.

About Dr. Kaveh Alizadeh

Dr. Kaveh Alizadeh is a board-certified plastic surgeon and academic professor with more than 24 years of experience. His practice spans cosmetic and reconstructive procedures, including innovative options such as the NaturaBra technique for breast lifts. He has been recognized on multiple top doctor lists and has performed thousands of successful surgeries. The throughline is precision and patient-centered care.

His work extends beyond the operating room. Through a nonprofit organization, he helps train local surgeons worldwide so they can treat patients in their own communities with confidence and skill. The goal is practical and urgent: expand access to safe, effective care where it’s needed most.

Frequently Asked Questions

What topics will be covered at the Migraine Surgery Symposium?

The program will explore the anatomy and science behind migraine trigger sites and review surgical options for treating them, with insights shared through panel discussions and focused presentations.

Who is Dr. Kaveh Alizadeh?

He’s a board-certified plastic surgeon and academic professor with over 24 years of experience, known for his expertise in migraine surgery as well as a broad range of cosmetic and reconstructive procedures.

What outcomes has Dr. Alizadeh reported for migraine surgery?

He reports that 92% of his patients no longer meet the criteria for chronic headaches after surgery, with a sustained 60% cure rate. Many are able to reduce or discontinue prescription medications.

When is the symposium taking place?

The symposium will be held online on September 14, from 8:30 a.m. to 5:00 p.m. EST.

How might patients benefit from Dr. Alizadeh’s work?

Patients gain access to innovative surgical options for migraine treatment and comprehensive, experience-based care—supported by a broader commitment to training and improving access to quality surgery worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing Asthma Treatment Market Approaches 32 Billion USD

Updated Category News Views 77

Asthma Treatment Market Overview The global asthma treatment market is experiencing significant growth, driven primarily by an alarming increase in asthma cases worldwide. Numerous factors, such as the rise in smoking rates and escalating air pollution levels, contribute to deteriorating lung function, leading to higher asthma incidence. Additionally, awareness campaigns...

Continue Reading
Important Update for NET Power, Inc. (NPWR) Shareholders

Updated Category News Views 309

Significant Information for NET Power, Inc. Investors NET Power, Inc. is a notable player in the energy sector, focusing on innovative solutions to improve energy production efficiency. Shareholders of this company may want to pay attention to an ongoing class action lawsuit that has come to light, which aims to recover losses for investors affected by alleged securities...

Continue Reading
TWFG, Inc. Expands Insurance Services with New Acquisition

Updated Category News Views 214

TWFG, Inc. Strengthens Its Insurance Presence TWFG, Inc. (NASDAQ: TWFG), based in The Woodlands, Texas, is proudly expanding its reach. With an exciting acquisition of Alabama Insurance Agency, Inc. and its associated 20 locations, TWFG significantly boosts its footprint in the Southeastern United States. This move not only solidifies their market presence but also...

Continue Reading
Canadian Physician Consensus: Urgent Need for AI Regulations

Updated Category News Views 74

The Call for AI Regulation Among Canadian Physicians Recent findings from a comprehensive study indicate a strong consensus among Canadian healthcare professionals regarding the urgent need for regulation of artificial intelligence (AI) in medical practice. This striking development underscores the increasing influence of AI in healthcare and the responsibility of...

Continue Reading
Bristol Myers Squibb's New Approach in Alzheimer's Drug Study

Updated Category News Views 220

Bristol Myers Squibb Expands Alzheimer’s Study After Irregularities Bristol Myers Squibb & Co (NYSE: BMY) recently announced it will be increasing patient enrollment in the ADEPT-2 Phase 3 study. This decision comes in light of unexpected irregularities identified in the study's execution across certain clinical trial sites. Understanding the ADEPT-2 Study The ADEPT-2...

Continue Reading